Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65808

1.

The Evolution of Surgery: The Story of "Two Poems"

Freischlag JA, Kibbe MR.

JAMA. 2014 Oct 24. doi: 10.1001/jama.2014.14448. [Epub ahead of print] No abstract available.

PMID:
25343524
[PubMed - as supplied by publisher]
2.

JAMA patient page. Crohn disease.

Cheifetz A.

JAMA. 2014 Oct 22-29;312(16):1708. doi: 10.1001/jama.2014.7962. No abstract available.

PMID:
25335164
[PubMed - in process]
3.

The cost of medical care.

[No authors listed]

JAMA. 2014 Oct 22-29;312(16):1699. doi: 10.1001/jama.2013.279804. No abstract available.

PMID:
25335163
[PubMed - in process]
4.

Addressing the trauma of hospitalization--reply.

Detsky AS, Krumholz HM.

JAMA. 2014 Oct 22-29;312(16):1697. doi: 10.1001/jama.2014.10179. No abstract available.

PMID:
25335161
[PubMed - in process]
5.

Addressing the trauma of hospitalization.

Davydow DS, Katon WJ.

JAMA. 2014 Oct 22-29;312(16):1696-7. doi: 10.1001/jama.2014.10149. No abstract available.

PMID:
25335160
[PubMed - in process]
6.

Insulin vs sulfonylureas for second-line diabetes treatment--reply.

Safford MM.

JAMA. 2014 Oct 22-29;312(16):1694-5. doi: 10.1001/jama.2014.11129. No abstract available.

PMID:
25335159
[PubMed - in process]
7.

Breast cancer screening with tomosynthesis and digital mammography.

Seidenwurm D, Rosenberg R.

JAMA. 2014 Oct 22-29;312(16):1695. doi: 10.1001/jama.2014.11117. No abstract available.

PMID:
25335158
[PubMed - in process]
8.

Breast cancer screening with tomosynthesis and digital mammography-reply.

Friedewald SM, Rafferty EA, Conant EF.

JAMA. 2014 Oct 22-29;312(16):1695-6. doi: 10.1001/jama.2014.11123. No abstract available.

PMID:
25335157
[PubMed - in process]
9.

Insulin vs sulfonylureas for second-line diabetes treatment.

Roumie CL, Greevy RA, Griffin MR.

JAMA. 2014 Oct 22-29;312(16):1694. doi: 10.1001/jama.2014.11126. No abstract available.

PMID:
25335156
[PubMed - in process]
10.

Insulin vs sulfonylureas for second-line diabetes treatment--reply.

Roumie CL, Greevy RA, Griffin MR.

JAMA. 2014 Oct 22-29;312(16):1693-4. doi: 10.1001/jama.2014.11120. No abstract available.

PMID:
25335155
[PubMed - in process]
11.

Insulin vs sulfonylureas for second-line diabetes treatment.

Tasci I, Safer U.

JAMA. 2014 Oct 22-29;312(16):1693. doi: 10.1001/jama.2014.11114. No abstract available.

PMID:
25335154
[PubMed - in process]
12.

Presence of banned drugs in dietary supplements following FDA recalls.

Cohen PA, Maller G, DeSouza R, Neal-Kababick J.

JAMA. 2014 Oct 22-29;312(16):1691-3. doi: 10.1001/jama.2014.10308. No abstract available.

PMID:
25335153
[PubMed - in process]
13.

Tests for urinary tract infection in nursing home residents.

Juthani-Mehta M, Datunashvili A, Tinetti M.

JAMA. 2014 Oct 22-29;312(16):1687-8. doi: 10.1001/jama.2014.13554. No abstract available.

PMID:
25335152
[PubMed - in process]
14.

Treatment of generalized war-related health concerns: placing TBI and PTSD in context.

Hoge CW, Castro CA.

JAMA. 2014 Oct 22-29;312(16):1685-6. doi: 10.1001/jama.2014.6670. No abstract available.

PMID:
25335151
[PubMed - in process]
15.

Diagnosis and management of urinary tract infections in the outpatient setting: a review.

Grigoryan L, Trautner BW, Gupta K.

JAMA. 2014 Oct 22-29;312(16):1677-84. doi: 10.1001/jama.2014.12842.

PMID:
25335150
[PubMed - in process]
16.

Association between availability of health service prices and payments for these services.

Whaley C, Schneider Chafen J, Pinkard S, Kellerman G, Bravata D, Kocher R, Sood N.

JAMA. 2014 Oct 22-29;312(16):1670-6. doi: 10.1001/jama.2014.13373.

PMID:
25335149
[PubMed - in process]
17.

Total expenditures per patient in hospital-owned and physician-owned physician organizations in California.

Robinson JC, Miller K.

JAMA. 2014 Oct 22-29;312(16):1663-9. doi: 10.1001/jama.2014.14072.

PMID:
25335148
[PubMed - in process]
18.

Physician practice competition and prices paid by private insurers for office visits.

Baker LC, Bundorf MK, Royalty AB, Levin Z.

JAMA. 2014 Oct 22-29;312(16):1653-62. doi: 10.1001/jama.2014.10921.

PMID:
25335147
[PubMed - in process]
19.

Association between hospital conversions to for-profit status and clinical and economic outcomes.

Joynt KE, Orav EJ, Jha AK.

JAMA. 2014 Oct 22-29;312(16):1644-52. doi: 10.1001/jama.2014.13336.

PMID:
25335146
[PubMed - in process]
20.

Health care price transparency and economic theory.

Reinhardt UE.

JAMA. 2014 Oct 22-29;312(16):1642-3. doi: 10.1001/jama.2014.14276. No abstract available.

PMID:
25335145
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk